Literature DB >> 29401021

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.

Angela Y Chang1, Carlos Riumallo-Herl2, Nicole A Perales3, Samantha Clark4, Andrew Clark5, Dagna Constenla6, Tini Garske7, Michael L Jackson8, Kévin Jean9, Mark Jit10, Edward O Jones11, Xi Li12, Chutima Suraratdecha13, Olivia Bullock14, Hope Johnson15, Logan Brenzel16, Stéphane Verguet17.   

Abstract

With social policies increasingly directed toward enhancing equity through health programs, it is important that methods for estimating the health and economic benefits of these programs by subpopulation be developed, to assess both equity concerns and the programs' total impact. We estimated the differential health impact (measured as the number of deaths averted) and household economic impact (measured as the number of cases of medical impoverishment averted) of ten antigens and their corresponding vaccines across income quintiles for forty-one low- and middle-income countries. Our analysis indicated that benefits across these vaccines would accrue predominantly in the lowest income quintiles. Policy makers should be informed about the large health and economic distributional impact that vaccines could have, and they should view vaccination policies as potentially important channels for improving health equity. Our results provide insight into the distribution of vaccine-preventable diseases and the health benefits associated with their prevention.

Entities:  

Keywords:  Children’s Health; Developing World < International/global health studies; Disparities; Health Economics

Mesh:

Substances:

Year:  2018        PMID: 29401021     DOI: 10.1377/hlthaff.2017.0861

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  23 in total

1.  Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunity.

Authors:  Boris Julg; Galit Alter
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

2.  Influence of socio-demographic factors on coverage of full vaccination among children aged 12-23 months: a study in Indian context (2015-2016).

Authors:  Tarikul Islam; Salim Mandal; Pradip Chouhan
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

3.  Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation.

Authors:  Solomon Tessema Memirie; Hailemichael Desalegn; Mulugeta Naizgi; Mulat Nigus; Lisanu Taddesse; Yared Tadesse; Fasil Tessema; Meseret Zelalem; Tsinuel Girma
Journal:  Cost Eff Resour Alloc       Date:  2020-07-22

4.  A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.

Authors:  Sarah N Cox; Patrick T Wedlock; Sarah W Pallas; Elizabeth A Mitgang; Tatenda T Yemeke; Sarah M Bartsch; Taiwo Abimbola; Sheryl S Sigemund; Aaron Wallace; Sachiko Ozawa; Bruce Y Lee
Journal:  Vaccine       Date:  2021-05-25       Impact factor: 3.641

5.  TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines.

Authors:  Irene Rivero-Calle; Jose Gómez-Rial; Louis Bont; Bradford D Gessner; Melvin Kohn; Ron Dagan; Daniel C Payne; Laia Bruni; Andrew J Pollard; Adolfo García-Sastre; Denise L Faustman; Albert Osterhaus; Robb Butler; Francisco Giménez Sánchez; Francisco Álvarez; Myrsini Kaforou; Xabier Bello; Federico Martinón-Torres
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

6.  Vaccine confidence: the keys to restoring trust.

Authors:  Selim Badur; Martin Ota; Serdar Öztürk; Richard Adegbola; Anil Dutta
Journal:  Hum Vaccin Immunother       Date:  2020-04-16       Impact factor: 3.452

7.  Inequalities in Rotavirus Vaccine Uptake in Ethiopia: A Decomposition Analysis.

Authors:  Abrham Wondimu; Jurjen van der Schans; Marinus van Hulst; Maarten J Postma
Journal:  Int J Environ Res Public Health       Date:  2020-04-14       Impact factor: 3.390

8.  Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination.

Authors:  Arindam Nandi; Anita Shet
Journal:  Hum Vaccin Immunother       Date:  2020-01-24       Impact factor: 3.452

9.  Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits.

Authors:  Andrew Stawasz; Liping Huang; Paige Kirby; David Bloom
Journal:  Front Public Health       Date:  2020-07-10

10.  Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt.

Authors:  Michael L Jackson; Alpha Oumar Diallo; Isaie Médah; Brice Wilfried Bicaba; Issaka Yaméogo; Daouda Koussoubé; Rasmata Ouédraogo; Lassané Sangaré; Sarah A Mbaeyi
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.